Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 43/72 ]
NYSE | Common Stock
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.
It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.
The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads.
The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors.
CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 24, 24 | 0.79 Increased by +19.70% | 0.74 Increased by +6.76% |
| Jan 8, 24 | 1.06 Increased by +152.38% | 1.11 Decreased by -4.50% |
| Oct 25, 23 | 0.90 Increased by +16.88% | 0.83 Increased by +8.43% |
| Jul 26, 23 | 0.83 Increased by +9.21% | 0.79 Increased by +5.06% |
| Apr 26, 23 | 0.66 Decreased by -5.71% | 0.60 Increased by +10.00% |
| Feb 2, 23 | 0.42 Decreased by -60.75% | 0.90 Decreased by -53.33% |
| Oct 26, 22 | 0.77 Decreased by -3.75% | 0.75 Increased by +2.67% |
| Jul 27, 22 | 0.76 Increased by +7.04% | 0.75 Increased by +1.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 304.58 M Increased by +10.72% | 15.84 M Decreased by -65.68% | Increased by +5.20% Decreased by -69.01% |
| Jun 30, 23 | 317.65 M Increased by +14.60% | 13.73 M Increased by +108.16% | Increased by +4.32% Increased by +107.12% |
| Mar 31, 23 | 295.47 M Increased by +21.93% | 1.82 M Decreased by -87.85% | Increased by +0.62% Decreased by -90.04% |
| Dec 31, 22 | 250.87 M Decreased by -8.43% | 26.58 M Increased by +8.75% | Increased by +10.60% Increased by +18.77% |
| Sep 30, 22 | 275.09 M Increased by +10.55% | 46.15 M Increased by +208.74% | Increased by +16.78% Increased by +179.26% |
| Jun 30, 22 | 277.19 M Increased by +8.63% | -168.29 M Decreased by -1.37 K% | Decreased by -60.71% Decreased by -1.27 K% |
| Mar 31, 22 | 242.33 M Increased by +4.15% | 14.97 M Increased by +51.88% | Increased by +6.18% Increased by +45.83% |
| Dec 31, 21 | 273.97 M Increased by +8.36% | 24.44 M Increased by +1.26% | Increased by +8.92% Decreased by -6.56% |